Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 19, 2017
Total Value: $396M (94.6% shares, 5.4% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ASSEMBLY BIOSCIENCES INC | 2,943,164 | $75.02M | 19.0% | $8.38 | — | COM | 045396108 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 2,905,515 | $49.57M | 12.5% | $9.45 | +44.6% | COM | 46333X108 |
| GLPG | GALAPAGOS NV | 551,041 | $47.49M | 12.0% | $57.70 | — | SPONSORED ADR | 36315X101 |
| — | GILEAD SCIENCES INC | 500,000 | $33.96M | 8.6% | — | — | Call | 375558903 |
| ASND | ASCENDIS PHARMA A S | 1,025,700 | $28.72M | 7.3% | $20.59 | — | SPONSORED ADR | 04351P101 |
| KURA | KURA ONCOLOGY INC COM | 2,611,906 | $22.98M | 5.8% | $10.12 | -27.5% | COM | 50127T109 |
| — | THERAVANCE BIOPHARMA INC | 17,000,000 | $21.44M | 5.4% | $1.14 | — | NOTE | 88339KAA0 |
| ACRS | ACLARIS THERAPEUTICS INC | 673,100 | $20.07M | 5.1% | $26.78 | +7.7% | COM | 00461U105 |
| CTMX | CYTOMX THERAPEUTICS INC | 794,969 | $13.73M | 3.5% | $13.16 | 0.0% | COM | 23284F105 |
| — | CASCADIAN THERAPEUTICS INC | 3,000,000 | $12.42M | 3.1% | $4.14 | — | COM | 14740B606 |
| FATE | FATE THERAPEUTICS INC | 2,537,026 | $11.54M | 2.9% | $3.66 | 0.0% | COM | 31189P102 |
| — | ATARA BIOTHERAPEUTICS INC | 434,812 | $8.935M | 2.3% | $17.40 | — | COM | 046513107 |
| — | ATYR PHARMA INC | 2,292,659 | $8.024M | 2.0% | $2.92 | — | COM | 002120103 |
| — | OVASCIENCE INC | 3,512,332 | $6.568M | 1.7% | $1.87 | — | COM | 69014Q101 |
| — | JOUNCE THERAPEUTICS INC | 258,457 | $5.683M | 1.4% | $21.99 | — | COM | 481116101 |
| XNCR | XENCOR INC | 234,813 | $5.617M | 1.4% | $24.05 | +0.2% | COM | 98401F105 |
| — | KINDRED BIOSCIENCES INC | 544,880 | $3.841M | 1.0% | $7.10 | — | COM | 494577109 |
| — | NABRIVA THERAPEUTICS AG | 264,773 | $3.177M | 0.8% | $9.50 | — | SPONSORED ADR | 62957M104 |
| — | REGULUS THERAPEUTICS INC | 1,510,000 | $2.492M | 0.6% | $1.65 | — | COM | 75915K101 |
| — | ADVERUM BIOTECHNOLOGIES INC | 874,447 | $2.361M | 0.6% | $4.11 | — | COM | 00773U108 |
| — | VERSARTIS INC | 100,000 | $2.135M | 0.5% | $21.35 | — | COM | 92529L102 |
| — | VIVEVE MED INC | 250,000 | $1.583M | 0.4% | $6.33 | — | COM | 92852W204 |
| AGIO | AGIOS PHARMACEUTICALS INC | 23,300 | $1.361M | 0.3% | $43.55 | +10.1% | COM | 00847X104 |
| — | DICERNA PHARMACEUTICALS INC | 382,000 | $1.299M | 0.3% | $3.40 | — | COM | 253031108 |
| — | FIBROGEN INC | 42,009 | $1.036M | 0.3% | $24.72 | — | COM | 31572Q808 |
| — | SYROS PHARMACEUTICALS INC | 63,596 | $1.013M | 0.3% | $13.87 | — | COM | 87184Q107 |
| BMY | BRISTOL MYERS SQUIBB CO | 17,060 | $928K | 0.2% | $39.73 | +0.5% | COM | 110122108 |
| — | CHEMOCENTRYX INC | 118,000 | $859K | 0.2% | $7.28 | — | COM | 16383L106 |
| SNDX | SYNDAX PHARMACEUTICALS INC COM | 35,301 | $484K | 0.1% | $12.54 | -17.2% | COM | 87164F105 |
| — | CASCADIAN THERAPEUTICS INC | 103,800 | $430K | 0.1% | — | — | Call | 14740B906 |
| — | OREXIGEN THERAPEUTICS INC | 117,726 | $405K | 0.1% | $3.44 | — | COM | 686164302 |
| WVE | WAVE LIFE SCIENCES LTD | 10,000 | $275K | 0.1% | $27.93 | 0.0% | SHS | Y95308105 |
| — | FORWARD PHARMA A/S | 5,025 | $108K | 0.0% | $21.49 | — | SPONSORED ADR | 34986J105 |